HK1083462A1 - Compounds for the treatment of metabolic disorders - Google Patents

Compounds for the treatment of metabolic disorders

Info

Publication number
HK1083462A1
HK1083462A1 HK06103530.5A HK06103530A HK1083462A1 HK 1083462 A1 HK1083462 A1 HK 1083462A1 HK 06103530 A HK06103530 A HK 06103530A HK 1083462 A1 HK1083462 A1 HK 1083462A1
Authority
HK
Hong Kong
Prior art keywords
sup
carbon atoms
ring
alkyl
hydrogen
Prior art date
Application number
HK06103530.5A
Other languages
English (en)
Inventor
Kirvin L Hodge
Robert J Kaufman
Albert Lee
Shalini Sharma
Borstel Reid W Von
Original Assignee
Wellstat Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellstat Therapeutics Corp filed Critical Wellstat Therapeutics Corp
Publication of HK1083462A1 publication Critical patent/HK1083462A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06103530.5A 2003-04-22 2006-03-21 Compounds for the treatment of metabolic disorders HK1083462A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46455303P 2003-04-22 2003-04-22
PCT/US2004/012142 WO2004093806A2 (fr) 2003-04-22 2004-04-20 Composes pour le traitement de troubles metaboliques

Publications (1)

Publication Number Publication Date
HK1083462A1 true HK1083462A1 (en) 2006-07-07

Family

ID=33310913

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06103530.5A HK1083462A1 (en) 2003-04-22 2006-03-21 Compounds for the treatment of metabolic disorders

Country Status (9)

Country Link
US (1) US7361686B2 (fr)
EP (1) EP1618086B1 (fr)
JP (1) JP4697973B2 (fr)
CN (1) CN1777576A (fr)
AT (1) ATE450496T1 (fr)
CA (1) CA2521589C (fr)
DE (1) DE602004024382D1 (fr)
HK (1) HK1083462A1 (fr)
WO (1) WO2004093806A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530051A (en) * 2001-06-12 2006-12-22 Wellstat Therapeutics Corp Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders
JP4697962B2 (ja) * 2003-02-13 2011-06-08 ウェルスタット セラピューティクス コーポレイション 代謝性障害の処置のための化合物
PT1633340E (pt) * 2003-04-15 2011-02-22 Wellstat Therapeutics Corp Compostos para o tratamento de distúrbios metabólicos
CA2522738C (fr) * 2003-04-30 2011-11-08 Wellstat Therapeutics Corporation Composes destines au traitement de troubles metaboliques
US7906675B2 (en) * 2003-08-20 2011-03-15 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
ATE540675T1 (de) * 2005-04-01 2012-01-15 Wellstat Therapeutics Corp Verbindungen zur behandlung von stoffwechselstörungen
UA95613C2 (ru) * 2005-11-09 2011-08-25 Уеллстат Терепьютикс Корпорейшн Соединения для лечения расстройсв метаболизма
WO2007087505A2 (fr) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Composés destinés au traitement des troubles du métabolisme
KR20080086523A (ko) * 2006-01-25 2008-09-25 웰스태트 테러퓨틱스 코포레이션 물질대사 장애의 치료용 화합물
WO2007087504A2 (fr) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Composés destinés au traitement des troubles du métabolisme
CA2639939A1 (fr) * 2006-02-02 2007-08-16 Wellstat Therapeutics Corporation Composes pour le traitement de troubles metaboliques
CA2637884A1 (fr) * 2006-02-13 2007-08-23 Wellstat Therapeutics Corporation Composes pour le traitement de troubles du metabolisme
MX2008011022A (es) * 2006-02-28 2008-09-10 Wellstat Therapeutics Corp Compuestos para el tratamiento de trastornos metabolicos.
AU2007235145B2 (en) * 2006-03-31 2011-09-22 Wellstat Therapeutics Corporation Combination treatment of metabolic disorders
CN101437506A (zh) * 2006-05-18 2009-05-20 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
EP2026659A4 (fr) * 2006-06-09 2010-06-30 Wellstat Therapeutics Corp Composés destinés au traitement de troubles métaboliques
US8481595B2 (en) * 2008-01-15 2013-07-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
WO2009137381A1 (fr) * 2008-05-05 2009-11-12 Wellstat Therapeutics Corporation Synthèse de l’acide 4-[3-(2,6-diméthylbenzyloxy)phényl]-4-oxobutanoïque
EP2365746B1 (fr) 2008-11-04 2014-07-16 Wellstat Therapeutics Corporation Synthèse d'acides (phénylalkyloxy)phényl-oxobutanoïques

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419952A1 (de) * 1984-05-28 1985-11-28 Bayer Ag, 5090 Leverkusen Substituierte phenoxyphenylpropionsaeure-derivate
DE3621775A1 (de) 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4897397A (en) * 1988-12-16 1990-01-30 Schering Corporation Aryl-alkynoic, alkenoic or alkanoic compounds and compositions useful as antiallergy and anti-inflammatory agents
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
WO1995004025A1 (fr) * 1993-07-29 1995-02-09 Chugai Seiyaku Kabushiki Kaisha Derive d'acide tricarboxylique a activite d'inhibition de la squalene-synthetase
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
JP3880108B2 (ja) * 1994-11-02 2007-02-14 武田薬品工業株式会社 ２，４−オキサゾリジンジオン誘導体、その製造法およびそれを含んでなる医薬組成物
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
JP4148681B2 (ja) * 2000-12-28 2008-09-10 武田薬品工業株式会社 アルカン酸誘導体、その製造法および用途
EP1357115B1 (fr) 2000-12-28 2009-06-17 Takeda Pharmaceutical Company Limited Derives d'acide alcanoique, procede de production et utilisation correspondants
NZ530051A (en) * 2001-06-12 2006-12-22 Wellstat Therapeutics Corp Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders
EP1556085A4 (fr) 2002-11-01 2012-08-22 Wellstat Therapeutics Corp Composes destines au traitement de troubles metaboliques
JP4697962B2 (ja) 2003-02-13 2011-06-08 ウェルスタット セラピューティクス コーポレイション 代謝性障害の処置のための化合物
PT1633340E (pt) 2003-04-15 2011-02-22 Wellstat Therapeutics Corp Compostos para o tratamento de distúrbios metabólicos
CA2522738C (fr) * 2003-04-30 2011-11-08 Wellstat Therapeutics Corporation Composes destines au traitement de troubles metaboliques

Also Published As

Publication number Publication date
DE602004024382D1 (de) 2010-01-14
JP2006524252A (ja) 2006-10-26
ATE450496T1 (de) 2009-12-15
EP1618086B1 (fr) 2009-12-02
EP1618086A4 (fr) 2007-05-09
CA2521589A1 (fr) 2004-11-04
CA2521589C (fr) 2011-11-01
JP4697973B2 (ja) 2011-06-08
CN1777576A (zh) 2006-05-24
WO2004093806A3 (fr) 2005-04-07
US20070105955A1 (en) 2007-05-10
EP1618086A2 (fr) 2006-01-25
US7361686B2 (en) 2008-04-22
WO2004093806A2 (fr) 2004-11-04

Similar Documents

Publication Publication Date Title
HK1083462A1 (en) Compounds for the treatment of metabolic disorders
HK1083460A1 (en) Compounds for the treatment of metabolic disorders
HK1084026A1 (en) Compounds for the treatment of metabolic disorders
MXPA05008600A (es) Compuestos para el tratamiento de desordenes metabolicos.
UA95613C2 (ru) Соединения для лечения расстройсв метаболизма
ATE530066T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
WO2007095462A3 (fr) Composes pour le traitement de troubles du metabolisme
WO2007087505A3 (fr) Composés destinés au traitement des troubles du métabolisme
WO2007137008A3 (fr) Composés pour le traitement de troubles métaboliques
EP1868595A4 (fr) Composes pour le traitement de troubles metaboliques
WO2005105732A8 (fr) Composes methylaryl- ou heteroarylamides substitues
UA88772C2 (ru) Соединения для лечения расстройств метаболизма
WO2007087506A3 (fr) Composés destinés au traitement des troubles du métabolisme
WO2007087504A3 (fr) Composés destinés au traitement des troubles du métabolisme
WO2007092729A3 (fr) Composes pour le traitement de troubles metaboliques
MXPA06000651A (es) Uso de derivados de indazol para el tratamiento de dolor neuropatico.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130420